FDA SIDING WITH BIG MEDICINE TO CONTINUE PROSTATE CANCER ILLNESS!
FDA Postpones Decision on Lycopene/Cancer Health Claim for a Fifth Time
SAN DIEGO, CALIFORNIA - The FDA has requested a fifth extension on giving a decision on American Longevity’s health claim petition on the link between lycopene and a reduced risk of developing certain types of cancer until October 10, 2005.
American Longevity has compiled scientific studies indicating that consumption of tomatoes, tomato-based products and lycopene supplementation may reduce the incidence of prostate, lung and stomach cancers and submitted these to the agency in 2003, along with its petition.
A decision was initially expected on December 24, 2004. However in mid-December the agency informed American Longevity that the decision would be delayed until February 11, 2005, again until April 12, 2005, again until June 12, 2005, yet again until August 12, 2005 and finally they have requested an additional 60 day extension. In recent months the agency has asked for extensions in its review of seven other pending qualified health claim petitions citing a lack of agency resources.
In a letter dated July 7, U.S. Senators Tom Harkin and Orrin Hatch wrote Dr. Lester Crawford, the commissioner of the Food and Drug Administration (FDA) expressing their concern about the length of time it takes to get an approval for Qualified Health Claim Petitions. The letter specifically asked how many petitions the FDA currently had, the length of time it has taken to approve each one, how many full-time equivalents (FTEs) are devoted to review them and the grade levels of the reviewers. The senators offered the disposal of their staffs to meet with the FDA to solve the problem.
“To say that we are disappointed by this fifth request for an extension would be an understatement” states Steve Wallach of American Longevity. “Every extension further delays our ability to get this important information out to the general public. However, we look forward to getting approval on this lycopene/cancer health claim petition in October.”
American Longevity has submitted several Health Claim Petitions to the FDA and is responsible for the authorized Health Claim Petition for Selenium and its relationship to Cancer Risk Reduction. American Longevity has helped to defend the Health Claim Petition process through the courts and has submitted many official comments to the FDA on behalf of the nutrition industry, all in an effort to help consumers have more access to truthful information in order to base a more informed decision regarding their own health and wellness.
American Longevity is a leading designer of Dietary Supplements and cutting edge personal care and wellness lifestyle products. The company was founded in April of 1997 in San Diego, California by Joel D. Wallach BS, DVM, ND, and Ma Lan MD, MS. American Longevity markets its products worldwide, through a network of independent distributors.
HEROES/HEROINES FIGHT FDA - GET OMEGA 3 CLAIM APPROVED
9 Sept 2004 -- After the FDA got beat in court by these good guys, on the selenium health claim, the FDA learned not to suck lemons! Yesterday the Food and Drug Administration (FDA) authorized their qualified health claim linking consumption of omega-3 fatty acids with a reduced rate of coronary heart disease:
FDA APPROVED CLAIM
“Supportive but not conclusive research shows that consumption of EPA and DHA omega-3 fatty acids may reduce the risk of coronary heart disease. One serving of [name of food] provides [x] grams of EPA and DHA omega-3 fatty acids. [See nutrition information for total fat, saturated fat and cholesterol content.]
The announcement follows FDA consideration of a health claim petition filed by American Longevity and Life Extension Foundation Buyers Club seeking to amend the agency’s previously authorized health claim for omega-3 acids and Coronary Heart Disease (CHD).
The September 8th decision dramatically widens FDA’s former position regarding the relationship between dietary supplements containing omega-3 fatty acids and the resulting reduced risk of CHD. The former qualified health claim contained a substantively limiting disclaimer that failed to adequately assess the benefits of omega-3 fatty acids in reducing the risk of CHD. The FDA’s current qualified health claim more accurately describes the current state of the scientific evidence on the benefits of omega-3 fatty acids and extends use of the health claim to both dietary supplements and conventional foods. A copy of the FDA letter allowing the use of the claim may be obtained from Cynthia Lewis at Emord & Associates, 202-466-6937.
Now why didn't your company join in putting in this petition? It can be used by everybody in the industry but only Doc Wallach and Dirk Pearson/Sandy Shaw had the guts and money to do it for the good of the people in the United States. They are also the only nutritional companies to have nerve enough to sue the FDA in the past. See the article below, they are the only companies to fight the bad guys. Now you can tell your company they can use the claim above because it is public property. However, before your company uses it make them send $5,000 to Emord and Associates to defer part of the thousands spent getting this claim
through.